| Dr Brett Michael Wertman, MD | |
|
27800 Medical Center Rd, Suite 222, Mission Viejo, CA 92691-6410 | |
| (949) 276-2446 | |
| (949) 276-2449 |
| Full Name | Dr Brett Michael Wertman |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 21 Years |
| Location | 27800 Medical Center Rd, Mission Viejo, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043349772 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | A90231 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hoag Memorial Hospital Presbyterian | Newport beach, CA | Hospital |
| Mission Hospital Regional Med Center | Mission viejo, CA | Hospital |
| Sutter Santa Rosa Regional Hospital | Santa rosa, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ccoc, Inc. | 0840332474 | 3 |
| Hoag Memorial Hospital Presbyterian | 5799677860 | 24 |
News Archive
Researchers at Northwestern Medicine have taken the first step in bioengineering the human uterus to treat endometriosis, uterine-factor infertility and endometrial cancer.
Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced updated clinical data on CAL-101, the Company's oral, delta selective PI3K inhibitor, presented during two oral presentations at the 51st American Society of Hematology Annual Meeting in New Orleans.
Research published online in the European Heart Journal has found that the protective effect that tea has on the cardiovascular system is totally wiped out by adding milk.
Mobile phone text messaging is a powerful tool for improving quality of care, as shown by José António Nhavoto in his doctoral thesis in informatics at örebro University. He has developed and tested a method in Mozambique, helping patients with severe diseases to follow through with their treatments.
› Verified 2 days ago
| Entity Name | Hoag Memorial Hospital Presbyterian |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518951300 PECOS PAC ID: 5799677860 Enrollment ID: O20040325000901 |
News Archive
Researchers at Northwestern Medicine have taken the first step in bioengineering the human uterus to treat endometriosis, uterine-factor infertility and endometrial cancer.
Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced updated clinical data on CAL-101, the Company's oral, delta selective PI3K inhibitor, presented during two oral presentations at the 51st American Society of Hematology Annual Meeting in New Orleans.
Research published online in the European Heart Journal has found that the protective effect that tea has on the cardiovascular system is totally wiped out by adding milk.
Mobile phone text messaging is a powerful tool for improving quality of care, as shown by José António Nhavoto in his doctoral thesis in informatics at örebro University. He has developed and tested a method in Mozambique, helping patients with severe diseases to follow through with their treatments.
› Verified 2 days ago
| Entity Name | Ccoc, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285968909 PECOS PAC ID: 0840332474 Enrollment ID: O20100120000720 |
News Archive
Researchers at Northwestern Medicine have taken the first step in bioengineering the human uterus to treat endometriosis, uterine-factor infertility and endometrial cancer.
Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced updated clinical data on CAL-101, the Company's oral, delta selective PI3K inhibitor, presented during two oral presentations at the 51st American Society of Hematology Annual Meeting in New Orleans.
Research published online in the European Heart Journal has found that the protective effect that tea has on the cardiovascular system is totally wiped out by adding milk.
Mobile phone text messaging is a powerful tool for improving quality of care, as shown by José António Nhavoto in his doctoral thesis in informatics at örebro University. He has developed and tested a method in Mozambique, helping patients with severe diseases to follow through with their treatments.
› Verified 2 days ago
| Entity Name | Aristamd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235671660 PECOS PAC ID: 5092120816 Enrollment ID: O20210209000178 |
News Archive
Researchers at Northwestern Medicine have taken the first step in bioengineering the human uterus to treat endometriosis, uterine-factor infertility and endometrial cancer.
Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced updated clinical data on CAL-101, the Company's oral, delta selective PI3K inhibitor, presented during two oral presentations at the 51st American Society of Hematology Annual Meeting in New Orleans.
Research published online in the European Heart Journal has found that the protective effect that tea has on the cardiovascular system is totally wiped out by adding milk.
Mobile phone text messaging is a powerful tool for improving quality of care, as shown by José António Nhavoto in his doctoral thesis in informatics at örebro University. He has developed and tested a method in Mozambique, helping patients with severe diseases to follow through with their treatments.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brett Michael Wertman, MD 27800 Medical Center Rd, Suite 222, Mission Viejo, CA 92691-6410 Ph: (949) 276-2446 | Dr Brett Michael Wertman, MD 27800 Medical Center Rd, Suite 222, Mission Viejo, CA 92691-6410 Ph: (949) 276-2446 |
News Archive
Researchers at Northwestern Medicine have taken the first step in bioengineering the human uterus to treat endometriosis, uterine-factor infertility and endometrial cancer.
Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced updated clinical data on CAL-101, the Company's oral, delta selective PI3K inhibitor, presented during two oral presentations at the 51st American Society of Hematology Annual Meeting in New Orleans.
Research published online in the European Heart Journal has found that the protective effect that tea has on the cardiovascular system is totally wiped out by adding milk.
Mobile phone text messaging is a powerful tool for improving quality of care, as shown by José António Nhavoto in his doctoral thesis in informatics at örebro University. He has developed and tested a method in Mozambique, helping patients with severe diseases to follow through with their treatments.
› Verified 2 days ago
Amy Thu Bui, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 26800 Crown Valley Pkwy, Suite 230, Mission Viejo, CA 92691 Phone: 949-542-8004 Fax: 949-364-3682 | |
Michael Pm Truong, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 26800 Crown Valley Pkwy, Suite 230, Mission Viejo, CA 92691 Phone: 949-364-3330 Fax: 949-364-3682 | |
Erene Nawar Sami, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 26800 Crown Valley Pkwy Ste 485, Mission Viejo, CA 92691 Phone: 949-364-5830 | |
Dr. Paul A Wehrle, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 26800 Crown Valley Pkwy., Suite 100, Mission Viejo, CA 92691 Phone: 949-364-6000 Fax: 949-364-1647 | |
Dr. Eric Olson Benner, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 26800 Crown Valley Pkwy Ste 315, Mission Viejo, CA 92691 Phone: 949-364-6000 Fax: 949-364-1204 | |
Dr. Richard Jacob, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 26800 Crown Valley Pkwy, Suite 250, Mission Viejo, CA 92691 Phone: 949-364-3570 Fax: 949-364-3430 |